CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases.

The price has broken the triangle, and we can expect a bullish trend from here.

Summary of analysis and signal : 

Entry point: 86

stop-loss: 76

Take profit 1: 95

Take profit 2: 110